International researchers pinpointed a rare coding variation in the Phospholipase D3 (PLD3) gene which is more common in people with late-onset Alzheimer’s than non-sufferers. Find
VIDEO & IN-DEPTH ARTICLE The world’s 4 largest international Alzheimer’s genetic consortiums have joined forces. The goal? To win the war on Alzheimer’s. Since joining
Learn why neurologists wish they could prescribe experimental solanezumab to 15% of their Alzheimer’s patients. Solanezumab is Eli Lilly’s exciting, maturing attempt to create a
VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
A new experimental drug may rescue brain cells just as they begin to become impaired, stopping Alzheimer’s before it is even noticeable. Learn why researchers
Using Deep Brain Stimulation to treat Alzheimer’s is starting to take off. More patients are being added to clinical trials. Learn about the U.S. FDA’s
News on bexarotene demands explaining. In the Alzheimer’s lab, this FDA-approved anti-cancer drug improves memory. Since that is what matters to people, funding is pouring
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
VIDEO Kathy Sanford is the first person in the USA to have a pacemaker implanted in her brain to treat Alzheimer’s. The pacemaker sends electronic
Dr. Francis Collins, director of the National Institutes of Health (NIH), just gave Americans a dose of good news on Alzheimer’s research. Find out what
A major study finds up to 13% of people diagnosed with dementia may actually have a treatable liver-brain disorder called hepatic encephalopathy. The discovery could change how doctors and families approach memory loss in older adults.
As little as 1% increase in deep-sleep per year, for people over 60, translates into a 27% decreased risk of dementia.
NEW RESEARCH: A diabetes medication already helping millions, called Jardiance, improves memory, strengthens blood flow, and supports overall brain health in pre- and early Alzheimer’s.
Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.
Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.
Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.
A deep promise to be there for an Alzheimer’s parent, this heartwarming song was written as a tribute to families facing dementia.
No spam, only news and updates.
